| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.8M | — |
| R&D Expense | $21.4M | +51.0% |
| SG&A Expense | $35.4M | +46.8% |
| Operating Income | -$54.9M | -40.9% |
| Interest Expense | $131K | — |
| Pre-tax Income | $22.7M | -71.1% |
| Income Tax | -$1.1M | — |
| Net Income | $23.8M | -69.7% |
| EPS (Basic) | $0.17 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.5M | -30.0% |
| Accounts Receivable | $16.1M | — |
| Inventory | $912K | — |
| Current Assets | $187.1M | -43.6% |
| Total Assets | $461.8M | -6.5% |
| Current Liabilities | $12.9M | -35.1% |
| Total Liabilities | $39.3M | -66.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.4M | -131.3% |
| Capital Expenditures | $102.2M | +22.1% |
| Investing Cash Flow | $26.2M | -70.5% |
| Financing Cash Flow | $146K | -88.3% |
| Free Cash Flow | -$162.5M | -48.1% |
| EPS (Diluted) | $0.17 | -69.1% |
| Stockholders' Equity |
| $422.5M |
| +12.1% |